Amarin Corp Plc (AMRN)

[Jamaalish]

Any chance the FDA called the Adcom to give people a chance to try to poke holes in the study and raise any concerns the FDA hadn't thought of? I didn't get a chance to see the video, let alone attend in person, so I have no idea myself. But if basically no one was able to make a convincing case against the drug or find legitimate weaknesses, that's pretty encouraging. Because then it sounds like more a green light to give V a broader label.